The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Novavax Partners with Sanofi, Completes Nuvaxovid EU Marketing Authorization Transfer Receiving $25 Million Payment
Oct 07, 2025•8 months ago
Contract Type
partnership
Gaithersburg
Description
Novavax has successfully transferred its COVID-19 vaccine Nuvaxovid® marketing authorization to Sanofi in the EU, which has triggered a $25 million milestone payment. This partnership enhances Sanofi's ability to commercialize the vaccine while continuing to advance Novavax's growth strategy.
Company Information
Company
Novavax
Location
Gaithersburg, Maryland, United States
About
We’re making a difference in the health of people around the world by producing next generation vaccines that are accessible to more people. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our hopes. We do this work for the greater health of people everywhere. It’s more than our job. It’s our passion.
Gaithersburg